Idexx Laboratories Has Launched Catalyst Pancreatic Lipase Test For Canine And Feline Patients Suspected Of Pancreatitis, It Will Be Available In US And Canada This September, With Global Rollout To Over 70,000 Installed Base Planned In Q4 Of 2024
Portfolio Pulse from Benzinga Newsdesk
Idexx Laboratories has launched the Catalyst Pancreatic Lipase Test for canine and feline patients suspected of pancreatitis. The test will be available in the US and Canada this September, with a global rollout to over 70,000 installed bases planned for Q4 of 2024.
June 04, 2024 | 11:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Idexx Laboratories has introduced a new diagnostic test for pancreatitis in pets, which will be available in the US and Canada this September, with a global rollout planned for Q4 2024.
The launch of the Catalyst Pancreatic Lipase Test is a significant product development for Idexx Laboratories, potentially boosting its revenue and market position in the veterinary diagnostics sector. The initial availability in the US and Canada, followed by a global rollout, indicates a strategic expansion plan.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100